XML 94 R12.htm IDEA: XBRL DOCUMENT v2.4.0.6
Discontinued Operations and Assets Held for Sale
 12 Months Ended
Jun. 30, 2012
Discontinued Operations and Disposal Groups [Abstract]  
Discontinued Operations and Assets Held for Sale
Discontinued Operations and Assets Held for Sale
As discussed in Note 1, during the first quarter of fiscal 2010, we completed the spin-off of CareFusion. During the fourth quarter of fiscal 2010, we completed the sale of the United Kingdom-based Martindale injectable manufacturing business ("Martindale") within our Pharmaceutical segment, for $141 million, resulting in a pre-tax gain of $36 million. There were no assets and liabilities from businesses held for sale at June 30, 2012 and 2011. Cash flows from discontinued operations are presented separately in the consolidated statements of cash flows.
The results included in discontinued operations for fiscal 2012, 2011 and 2010 are summarized as follows:
(in millions)
2012 (1)
 
2011 (1)
 
2010 (2)
Revenue
$
—

 
$
—

 
$
691

Earnings before income taxes
$
—

 
$
1

 
$
91

Income tax expense
(1
)
 
(8
)
 
(36
)
Earnings/(loss) from discontinued operations
$
(1
)
 
$
(7
)
 
$
55

(1)
Primarily reflects subsequent changes in certain estimates made at the time of the Spin-Off.
(2)
Reflects the results of Martindale through the date of the sale, the results of CareFusion through August 31, 2009, the date the Spin-Off was completed and subsequent changes in certain estimates made at the time of the Spin-Off.
During the third quarter of fiscal 2010, we completed the sale of SpecialtyScripts and it met the criteria for classification as held for sale in our financial statements. The results of SpecialtyScripts are reported within earnings from continuing operations in the consolidated statements of earnings through the date of sale because it did not satisfy the criteria for classification as discontinued operations.